VTIX is trading 8.7% up at $3.50 after announcing a new collaboration with Rutgers University to develop AI-assisted VR therapy for neurodivergent children.
- The partnership leverages Virtuix’s Omni One platform and positions the company for potential entry into healthcare-related VR applications.
- Investors view the move as a significant new growth avenue following several recent down days in the stock.